{"name":"Bio-innova Co., Ltd","slug":"bio-innova-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Desogestrel-Test product","genericName":"Desogestrel-Test product","slug":"desogestrel-test-product","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Desogestrel-Test product","genericName":"Desogestrel-Test product","slug":"desogestrel-test-product","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOYk8zRHhZRDZhUFhUZ2RiU2FKRk9pRU9BY3A3S3FtbVFtTlhMOVVURURXc2k0NDRhalBueXRlVmIwbTJfNnNvc0NNb1M4VXZRSEV5eFZzQS1VdlQ4VWFFcG9la05XaUxLMFBSMC12NXB0aDVfMVpaSzZaT1RPRVZzd2JHUjhKakplakxzU3dxbkJDLUNvYS1HTmxtdEt6Wk1HcGtrQXh1VURXeXNSOV9ZX01sOVVjUGVoc0haLTMzS0N6UjZrR08ycEJ3TzVQYjllVVQxX2EwUU8yUEdDbmttYnh6REdPUdIB6wFBVV95cUxPMVk2cVNMbjNIMTlQZlo4UGgwaTM0bkpvSUVHbHV3dFA0ZlF3anNBT1d0dmdVb1hTYVJodm1kam5RMk9SdW14ZE5URHZUQU9uN0VaNlJuOFE1SmQ4N2hZVGRuTzNQazk3MGpBa3Vsb1Y4QzVqUnNnUjZySWtuNU1kck1sZ3hHVW5UWkVITkdhNUZTdmUxVHotV3loSFpvbm93ZXM4QWtlN3BKSmpsR0s2RWtBZ0hzZ1ducWQwM0RRSWFiUVlvQmtFYzl0MnRPNkE0b3d5YkxFcVZMTXRjSFJnNU44SUUybVpDc3g0?oc=5","date":"2024-12-04","type":"pipeline","source":"Medical Dialogues","summary":"Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel - Medical Dialogues","headline":"Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPX0o2bDZ5Wk5xblVLcVB2U0lWUTBKVUNFbndFcGRISDdON0pvOVFlZGZjSTZsTzVncjNNSC04cFhWVTgtcXNHXzFDT1pod002NlhlSjVxQ2Fpb0YwejBfMkp0aFBPTTYxcGVDSlMwSEp6TnhjU0tGdF9DSkdPaTRfRlF0RFdLUTR4RXlIUmIwQng0TzJCSG1DaWxCUGs0YWVYX3l3OWJCbGEtM3I1bjhJbk1rVnJQVFpoY2EyQ1VNSldkbnpua2NTNDFldWdrVW56eUdpZVdtOTNjaEpkbzJLREdCWEZrNE9hczhobmhVUXE5QdIB-AFBVV95cUxNekVnTWpOTnFna0RsaHo0ODd3cnpPR0dLTUtmT29NMktuTWYwbDM3M3NHd2lwajEzbmV4RDFfc0t2WmF1Nks4NWl2U1Z0X1h4U3p5YzVUeVZZVGp1X3A3NmQxT1FsWlg1Y2JyeVR4VUZsN3RfUDR0YkdDdDh2SDNaRzRjSFExb195S3BRdDVFWHBGcmJ6cm1pSnA0VnlvOEVnb0FhN1lNZHY2cEVQaUhqd2lJTkxCSlpCZlFSdFdnTWVzZWVVa0JMOEhNcHhCbVNkRUJST0xNTHJmeDY2NFJ5RkNmMHItVnFqVzdvMU0ycGlXb0JZdWJGTA?oc=5","date":"2024-10-29","type":"pipeline","source":"BusinessLine","summary":"Innova Captab distances itself from former promoters of Sharon Bio-Medicine amid raid reports - BusinessLine","headline":"Innova Captab distances itself from former promoters of Sharon Bio-Medicine amid raid reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQRjhibGtxNm9SbGUtT2hVN1ptX1BVUFdoeFU0ejRGbFgyXy1ncGFPeURLQ29QdFpCMG9iZlZweFNma3doaTExaUVTaEIzdmdPcmFscW5qVy15Ny1hcEFIQjFSUHBTTWZwV0FRVjlJbTJvQm4zR3NJb0tTMXpraWQwNHJ5MmdVaDZ4b1HSAZABQVVfeXFMTllyejZPa0lWT3c0Ry1vRHJfXzNfbFFfN2c0MGhfRkNZVkZjZFV2dGtBTDVvVmwzVGxfVnYxYk4wOWV1N3JfbHl0eGdTVGNvb21UUEhDU2xZX1NvcGtBUm1uMjhPNGljNjBBRlJzWDVQQTFyZmM0b1lZRUVvRGItU2xRQXlRcXJsZUlvNVM4RXBm?oc=5","date":"2024-03-23","type":"pipeline","source":"Indian Pharma Post","summary":"Sharon Bio-Medicine resumes operations - Indian Pharma Post","headline":"Sharon Bio-Medicine resumes operations","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-12-29","type":"pipeline","source":"Business Standard","summary":"Innova Captab makes quiet debut at 2% premium; strengthens post listing - Business Standard","headline":"Innova Captab makes quiet debut at 2% premium; strengthens post listing","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-08-31","type":"pipeline","source":"Mint","summary":"Innova Captab places ₹400 cr bid for Sharon Bio-Medicine - Mint","headline":"Innova Captab places ₹400 cr bid for Sharon Bio-Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPUVhiQXBjSmpNNEtxUTdRS3BCVjlzRzRTcHlRbEpEcFpTd0FUN0Nic0JKeGVpN2hpVGhaN25SUVE3WThEQWRFcDRtRTRoMElQZlJCX1lKdWZXem15a1RUSVRJS243VDk2N1Z5Zmw3OW5ub0M5bWtXOFVVaThiR0ppVXQ3aVhBcW9J?oc=5","date":"2022-03-31","type":"pipeline","source":"The Edge Malaysia","summary":"Cover Story: Pharmaniaga readying for a 2024 lift-off - The Edge Malaysia","headline":"Cover Story: Pharmaniaga readying for a 2024 lift-off","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1rV1p0MzRFQTRzakdjOHgyYmZ4X3JlY3R2OWlwUGpWWkxSM2dac2lxRVdJSExaRkpiQXlTc2RLM2VVQmNXQnZrdGRQV1VhY05pbFlkMHd0U2RoUQ?oc=5","date":"2022-02-25","type":"pipeline","source":"bernama","summary":"Pharmaniaga Lifescience tie-up with Thai firm will reduce Malaysia's dependency on imported vaccine, says MITI - bernama","headline":"Pharmaniaga Lifescience tie-up with Thai firm will reduce Malaysia's dependency on imported vaccine, says MITI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzX2hzX3F3VTlXelM5S3J3Q1IzWFBjTVh5ek11cFpyclJpVk95dUIweVpIZlRSSHJ5NG1DMGdWNG1aSUxRdURyMkliTl9OYmFMSm9VODJaVi1CQQ?oc=5","date":"2022-02-25","type":"pipeline","source":"bernama","summary":"Prime Minister Ismail Sabri witnesses signing of three MoUs in Bangkok - bernama","headline":"Prime Minister Ismail Sabri witnesses signing of three MoUs in Bangkok","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}